4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-26-002576
Options or other derivatives
- Chief Scientific Officer acquired 166,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lorrain Daniel S. · Chief Scientific Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-30 | Grant or award : show line 1 in the form Stock Option (right to buy) | +160,000 | 160,000 | D |
| 2026-01-30 | Grant or award : show line 2 in the form Stock Option (right to buy) | +6,500 | 6,500 | I |
Loading xslF345X05/rdgdoc.xml…